Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""CONVALESCENCE"" wg kryterium: Temat


Tytuł :
COVID-19-convalescence phase unmasks a silent myocardial infarction due to coronary plaque rupture.
Autorzy :
Tschöpe C; Department of Cardiology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.; Berlin Institute of Health (BIH) Berlin-Brandenburg Center for Regenerative Therapy (BCRT), Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.; Deutsches Zentrum für Herz Kreislauf Forschung (DZHK), Standort Berlin/Charité, Berlin, Germany.
Sherif M; Department of Cardiology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.
Anker MS; Deutsches Zentrum für Herz Kreislauf Forschung (DZHK), Standort Berlin/Charité, Berlin, Germany.; Division of Cardiology and Metabolism, Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin-Franklin, Berlin, Germany.; Berlin Institute of Health Center for Regenerative Therapies (BCRT), Berlin, Germany.
Geisel D; Department of Radiology, Campus Virchow Klinikum, Charité-University Medicine Berlin, Berlin, Germany.
Kuehne T; Deutsches Zentrum für Herz Kreislauf Forschung (DZHK), Standort Berlin/Charité, Berlin, Germany.; Department of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.; Institute for Imaging Science and Computational Modelling in Cardiovascular Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Kelle S; Department of Cardiology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany.; Deutsches Zentrum für Herz Kreislauf Forschung (DZHK), Standort Berlin/Charité, Berlin, Germany.; Department of Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.
Pokaż więcej
Źródło :
ESC heart failure [ESC Heart Fail] 2021 Apr; Vol. 8 (2), pp. 971-973. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Convalescence*
COVID-19/*complications
Myocardial Infarction/*diagnosis
Myocardial Infarction/*etiology
Plaque, Atherosclerotic/*diagnosis
Plaque, Atherosclerotic/*etiology
Aged ; Humans ; Male ; Myocardial Infarction/therapy ; Plaque, Atherosclerotic/therapy ; Stroke Volume
Czasopismo naukowe
Tytuł :
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Autorzy :
Andreano E; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Nicastri E; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
Paciello I; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Pileri P; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Manganaro N; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Piccini G; VisMederi S.r.l, Siena, Italy.
Manenti A; VisMederi S.r.l, Siena, Italy; VisMederi Research S.r.l., Siena, Italy.
Pantano E; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Kabanova A; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy; Tumour Immunology Unit, Fondazione Toscana Life Sciences, Siena, Italy.
Troisi M; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.
Vacca F; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.
Cardamone D; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy; University of Turin, Turin, Italy.
De Santi C; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Benincasa L; VisMederi Research S.r.l., Siena, Italy.
Jang H; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA.
Di Genova C; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Chatham, UK.
Depau L; MedBiotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Brunetti J; MedBiotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Agrati C; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
Capobianchi MR; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
Castilletti C; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
Emiliozzi A; Department of Medical Biotechnologies, University of Siena, Siena, Italy; Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, Siena, Italy.
Fabbiani M; Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, Siena, Italy.
Montagnani F; Department of Medical Biotechnologies, University of Siena, Siena, Italy; Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, Siena, Italy.
Bracci L; MedBiotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Sautto G; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA.
Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA 30602, USA; Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA.
Montomoli E; VisMederi S.r.l, Siena, Italy; VisMederi Research S.r.l., Siena, Italy; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Chatham, UK.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Sala C; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Ippolito G; National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
Rappuoli R; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy; Faculty of Medicine, Imperial College, London, UK. Electronic address: .
Pokaż więcej
Źródło :
Cell [Cell] 2021 Apr 01; Vol. 184 (7), pp. 1821-1835.e16. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/immunology
COVID-19*/prevention & control
COVID-19*/therapy
Convalescence*
Antibodies, Monoclonal/*administration & dosage
Antibodies, Neutralizing/*administration & dosage
Antibodies, Viral/*administration & dosage
B-Lymphocytes/*immunology
3T3 Cells ; Animals ; Antibodies, Monoclonal/isolation & purification ; Antibodies, Neutralizing/isolation & purification ; Antibodies, Viral/isolation & purification ; B-Lymphocytes/cytology ; Chlorocebus aethiops ; Disease Models, Animal ; Female ; HEK293 Cells ; Humans ; Immunoglobulin Fc Fragments/immunology ; Male ; Mice ; Spike Glycoprotein, Coronavirus/immunology ; Vero Cells
Czasopismo naukowe
Tytuł :
The Potential of Developing Pan-Coronaviral Antibodies to Spike Peptides in Convalescent COVID-19 Patients.
Autorzy :
Rabets A; Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Bila G; Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Grytsko R; Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Samborskyy M; Explogen LLC, Lviv, Ukraine.
Rebets Y; Explogen LLC, Lviv, Ukraine.
Vari SG; International Research and Innovation in Medicine Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Pagneux Q; University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, UMR 8520, IEMN, Lille, France.
Barras A; University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, UMR 8520, IEMN, Lille, France.
Boukherroub R; University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, UMR 8520, IEMN, Lille, France.
Szunerits S; University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, UMR 8520, IEMN, Lille, France.
Bilyy R; Danylo Halytsky Lviv National Medical University, Lviv, Ukraine. .
Pokaż więcej
Źródło :
Archivum immunologiae et therapiae experimentalis [Arch Immunol Ther Exp (Warsz)] 2021 Mar 06; Vol. 69 (1), pp. 5. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article
MeSH Terms :
Convalescence*
Antibodies, Viral/*immunology
COVID-19/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Cross Reactions ; Humans ; Middle East Respiratory Syndrome Coronavirus/immunology ; SARS Virus/immunology
Czasopismo naukowe
Tytuł :
Implementation of a Recuperation Unit and Hospitalization Rates Among People Experiencing Homelessness With COVID-19.
Autorzy :
Barocas JA; Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts.; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.; Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts.
Gai MJ; Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts.
White LF; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Faretra D; Strategy Team, Boston Medical Center, Boston, Massachusetts.
Sachs K; Strategy Team, Boston Medical Center, Boston, Massachusetts.
Komaromy M; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.; Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts.; Section of General Internal Medicine, Boston Medical Center, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2021 Mar 01; Vol. 4 (3), pp. e212826. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Convalescence*
Delivery of Health Care*
Homeless Persons*
Hospital Units*
Patient Isolation*
COVID-19/*therapy
Hospitalization/*statistics & numerical data
Boston ; COVID-19/complications ; Disease Management ; Female ; Humans ; Interrupted Time Series Analysis ; Male ; Quarantine ; SARS-CoV-2 ; Substance-Related Disorders/complications ; Substance-Related Disorders/therapy
Czasopismo naukowe
Tytuł :
Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.
Autorzy :
Gattinger P; Department of Pathophysiology and Allergy Research, Division of Immunopathology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Borochova K; Department of Pathophysiology and Allergy Research, Division of Immunopathology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Dorofeeva Y; Department of Pathophysiology and Allergy Research, Division of Immunopathology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Henning R; Viravaxx, Vienna, Austria.
Kiss R; Viravaxx, Vienna, Austria.
Kratzer B; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Mühl B; Labors.at, Vienna, Austria.
Perkmann T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Trapin D; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Trella M; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Ettel P; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Tulaeva I; Department of Pathophysiology and Allergy Research, Division of Immunopathology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.; Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia.
Pickl WF; Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Valenta R; Department of Pathophysiology and Allergy Research, Division of Immunopathology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.; Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia.; NRC Institute of Immunology FMBA of Russia, Moscow, Russia.; Karl Landsteiner University of Health Sciences, Krems, Austria.
Pokaż więcej
Źródło :
Allergy [Allergy] 2021 Mar; Vol. 76 (3), pp. 878-883. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Convalescence*
Angiotensin-Converting Enzyme 2/*metabolism
Antibodies, Viral/*blood
COVID-19/*diagnosis
Receptors, Coronavirus/*metabolism
SARS-CoV-2/*immunology
Adolescent ; Adult ; Aged ; Binding Sites ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Middle Aged ; Young Adult
Raport
Tytuł :
Severe liver injury of coronavirus disease 2019 (COVID-19) in recovery.
Autorzy :
Zhou WQ; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Chen Y; Department of Infectious Diseases, Huangmei People's Hospital, Huanggang, Hubei Province, China.
Liu D; Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
Yang DL; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Zheng X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Pokaż więcej
Źródło :
Journal of digestive diseases [J Dig Dis] 2021 Mar; Vol. 22 (3), pp. 167-170. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Convalescence*
COVID-19/*therapy
Liver Diseases/*etiology
Adult ; COVID-19/diagnostic imaging ; Chemical and Drug Induced Liver Injury/etiology ; Drugs, Chinese Herbal/adverse effects ; Humans ; Male ; SARS-CoV-2 ; Sepsis/complications
Raport
Tytuł :
Hematologic changes predict clinical outcome in recovered patients with COVID-19.
Autorzy :
Mao J; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China.; Eighth Batch Chongqing Medical Aid Team to Wuhan City of Hubei Province, Chongqing, People's Republic of China.
Dai R; Department of Cardiology, Wuhan No.1 Hospital, Zhongshan Avenue 215#, Wuhan, 430022, Hubei, China.
Du RC; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China.; Eighth Batch Chongqing Medical Aid Team to Wuhan City of Hubei Province, Chongqing, People's Republic of China.
Zhu Y; Department of Hematology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Shui LP; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China.
Luo XH; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing, 400016, People's Republic of China. .; Eighth Batch Chongqing Medical Aid Team to Wuhan City of Hubei Province, Chongqing, People's Republic of China. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2021 Mar; Vol. 100 (3), pp. 675-689. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Cell Count*
Convalescence*
SARS-CoV-2*
COVID-19/*blood
Adult ; Aged ; Basophils ; C-Reactive Protein/analysis ; COVID-19/drug therapy ; COVID-19/epidemiology ; COVID-19/physiopathology ; COVID-19/therapy ; China ; Combined Modality Therapy ; Comorbidity ; Diabetes Mellitus/blood ; Diabetes Mellitus/epidemiology ; Eosinophils ; Female ; Hemoglobins/analysis ; Humans ; Hypertension/blood ; Hypertension/epidemiology ; Interleukin-6/blood ; Lung/physiopathology ; Male ; Middle Aged ; Oxygen Inhalation Therapy ; Prognosis ; Treatment Outcome
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
Autorzy :
Kared H; ImmunoScape, Singapore, Singapore.
Redd AD; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.; Department of Medicine and.
Bloch EM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Bonny TS; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sumatoh H; ImmunoScape, Singapore, Singapore.
Kairi F; ImmunoScape, Singapore, Singapore.
Carbajo D; ImmunoScape, Singapore, Singapore.
Abel B; ImmunoScape, Singapore, Singapore.
Newell EW; ImmunoScape, Singapore, Singapore.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Bettinotti MP; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Benner SE; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Patel EU; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology and.
Littlefield K; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Laeyendecker O; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.; Department of Medicine and.
Shoham S; Department of Medicine and.
Sullivan D; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Casadevall A; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Pekosz A; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Nardin A; ImmunoScape, Singapore, Singapore.
Fehlings M; ImmunoScape, Singapore, Singapore.
Tobian AA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Quinn TC; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.; Department of Medicine and.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Mar 01; Vol. 131 (5).
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Convalescence*
Models, Immunological*
CD8-Positive T-Lymphocytes/*immunology
COVID-19/*immunology
SARS-CoV-2/*immunology
Adult ; Aged ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; CD8-Positive T-Lymphocytes/pathology ; COVID-19/pathology ; Female ; HLA Antigens/immunology ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors.
Autorzy :
Mor M; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Werbner M; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Alter J; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Safra M; Alexander Kofkin Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel.
Chomsky E; ImmunAi, New York, New York, United States of America.
Lee JC; School of Medicine, University of California San Diego, La Jolla, California, United States of America.
Hada-Neeman S; George S. Wise Life sciences Faculty, Tel Aviv University, Tel-Aviv, Israel.
Polonsky K; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Nowell CJ; Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia.
Clark AE; School of Medicine, University of California San Diego, La Jolla, California, United States of America.
Roitburd-Berman A; George S. Wise Life sciences Faculty, Tel Aviv University, Tel-Aviv, Israel.
Ben-Shalom N; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Navon M; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Rafael D; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Sharim H; ImmunAi, New York, New York, United States of America.
Kiner E; ImmunAi, New York, New York, United States of America.
Griffis ER; Nikon Imaging Center, University of California San Diego, California, United States of America.
Gershoni JM; George S. Wise Life sciences Faculty, Tel Aviv University, Tel-Aviv, Israel.
Kobiler O; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Leibel SL; School of Medicine, University of California San Diego, La Jolla, California, United States of America.
Zimhony O; Kaplan Medical Center, Rehovot, Israel.
Carlin AF; School of Medicine, University of California San Diego, La Jolla, California, United States of America.
Yaari G; Alexander Kofkin Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel.
Dessau M; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Gal-Tanamy M; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Hagin D; Ichilov Hospital, Tel-Aviv, Israel.
Croker BA; School of Medicine, University of California San Diego, La Jolla, California, United States of America.
Freund NT; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2021 Feb 11; Vol. 17 (2), pp. e1009165. Date of Electronic Publication: 2021 Feb 11 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal*/genetics
Antibodies, Monoclonal*/immunology
Antibodies, Neutralizing*/genetics
Antibodies, Neutralizing*/immunology
Antibodies, Viral*/genetics
Antibodies, Viral*/immunology
COVID-19*/genetics
COVID-19*/immunology
Convalescence*
SARS-CoV-2*/immunology
Spike Glycoprotein, Coronavirus*/genetics
Spike Glycoprotein, Coronavirus*/immunology
Adult ; Aged ; Animals ; Chlorocebus aethiops ; Cloning, Molecular ; Epitope Mapping ; Epitopes/genetics ; Epitopes/immunology ; Female ; Humans ; Immunoglobulin G/genetics ; Immunoglobulin G/immunology ; Male ; Middle Aged ; Vero Cells
Czasopismo naukowe
Tytuł :
Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19.
Autorzy :
Machado FVC; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands. .; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. .; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands. .; Laboratory of Research in Respiratory Physiotherapy (LFIP), Department of Physiotherapy, State University of Londrina (UEL), Londrina, Brazil. .
Meys R; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Delbressine JM; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.
Vaes AW; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.
Goërtz YMJ; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
van Herck M; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.; REVAL Rehabilitation Research Center, BIOMED Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.
Houben-Wilke S; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.
Boon GJAM; Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
Barco S; Center for Thrombosis and Haemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.
Burtin C; REVAL Rehabilitation Research Center, BIOMED Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.
van 't Hul A; Department of Respiratory Diseases, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Posthuma R; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Franssen FME; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Spies Y; Lung Foundation Netherlands, Amersfoort, The Netherlands.
Vijlbrief H; Lung Foundation Netherlands, Amersfoort, The Netherlands.
Pitta F; Laboratory of Research in Respiratory Physiotherapy (LFIP), Department of Physiotherapy, State University of Londrina (UEL), Londrina, Brazil.
Rezek SA; Institute of Therapies and Rehabilitation, Kantonsspital Winterthur, Winterthur, Switzerland.
Janssen DJA; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.; Department of Health Services Research, Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Siegerink B; Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Klok FA; Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.; Center for Thrombosis and Haemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Spruit MA; Department of Research and Development, CIRO+, PO Box 4080, 6080 AB, Horn, Haelen, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Respiratory Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.; REVAL Rehabilitation Research Center, BIOMED Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.
Pokaż więcej
Źródło :
Health and quality of life outcomes [Health Qual Life Outcomes] 2021 Feb 03; Vol. 19 (1), pp. 40. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :
Journal Article
MeSH Terms :
Convalescence*
Functional Status*
Quality of Life*
COVID-19/*physiopathology
Adult ; Belgium ; COVID-19/psychology ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Netherlands ; Reproducibility of Results ; SARS-CoV-2 ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
Autorzy :
Yamamoto S; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Saito M; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Nagai E; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Toriuchi K; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Nagai H; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Yotsuyanagi H; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Nakagama Y; Department of Parasitology, Graduate Scholl of Medicine, Osaka City University, Osaka, Japan.
Kido Y; Department of Parasitology, Graduate Scholl of Medicine, Osaka City University, Osaka, Japan.
Adachi E; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Feb; Vol. 93 (2), pp. 692-694. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :
Letter
MeSH Terms :
Convalescence*
Seroconversion*
Antibodies, Viral/*blood
COVID-19/*immunology
Adult ; Aged ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Longitudinal Studies ; Male ; Middle Aged ; Retrospective Studies ; SARS-CoV-2/immunology
Opinia redakcyjna
Tytuł :
Clinical Features for Identifying the Possibility of Toileting Independence after Convalescent Inpatient Rehabilitation in Severe Stroke Patients: A Decision Tree Analysis Based on a Nationwide Japan Rehabilitation Database.
Autorzy :
Imura T; Department of Rehabilitation, Faculty of Health Sciences, Hiroshima Cosmopolitan University, 731-3166, 3-2-1, Otsuka-higashi, Hiroshima, Japan. Electronic address: .
Inoue Y; Research Institute of Health and Welfare, Kibi International University, Okayama, Japan.
Tanaka R; Graduate School of Humanities and Social Sciences, Hiroshima University, Hiroshima, Japan.
Matsuba J; Department of Tokyo Physical Therapy, Teikyo University of Science, Tokyo, Japan.
Umayahara Y; Department of Rehabilitation, Faculty of Health Sciences, Hiroshima Cosmopolitan University, 731-3166, 3-2-1, Otsuka-higashi, Hiroshima, Japan.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Feb; Vol. 30 (2), pp. 105483. Date of Electronic Publication: 2020 Nov 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Convalescence*
Decision Support Techniques*
Decision Trees*
Defecation*
Functional Status*
Inpatients*
Stroke Rehabilitation*
Urination*
Stroke/*therapy
Age Factors ; Aged ; Aged, 80 and over ; Algorithms ; Databases, Factual ; Disability Evaluation ; Female ; Humans ; Japan ; Male ; Middle Aged ; Predictive Value of Tests ; Recovery of Function ; Severity of Illness Index ; Stroke/diagnosis ; Stroke/physiopathology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months.
Autorzy :
Peng P; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Hu J; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Deng HJ; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Liu BZ; Yong-Chuan Hospital, Chongqing Medical University, Chongqing, 402160, China.
Fang L; Yong-Chuan Hospital, Chongqing Medical University, Chongqing, 402160, China.
Wang K; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. .
Tang N; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. .
Huang AL; Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. .
Pokaż więcej
Źródło :
Cellular & molecular immunology [Cell Mol Immunol] 2021 Feb; Vol. 18 (2), pp. 490-491. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Convalescence*
Immunity, Humoral*
COVID-19/*immunology
COVID-19/*virology
SARS-CoV-2/*physiology
Aged ; Female ; Humans ; Male ; Middle Aged ; Risk Factors
Raport
Tytuł :
Ebola virus antibody decay-stimulation in a high proportion of survivors.
Autorzy :
Adaken C; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK.; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), University of Liverpool, Liverpool, UK.
Scott JT; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), University of Liverpool, Liverpool, UK.; Faculty of Health and Life Science, University of Liverpool, Liverpool, UK.; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Sharma R; Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Gopal R; High Containment Microbiology, National Infections Service, Public Health England, London, UK.
Dicks S; Blood Borne Virus Unit, National Infection Service, Public Health England, London, UK.; Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.
Niazi S; Blood Borne Virus Unit, National Infection Service, Public Health England, London, UK.; Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.
Ijaz S; Blood Borne Virus Unit, National Infection Service, Public Health England, London, UK.; Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.
Edwards T; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
Smith CC; Faculty of Health and Life Science, University of Liverpool, Liverpool, UK.; Travel Medicine and International Health Team, Health Protection Scotland, Glasgow, UK.; Oxford Vaccine Group, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, UK.
Cole CP; College of Medicine and Allied Health Sciences, Freetown, Sierra Leone.; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
Kamara P; National Safe Blood Service, Ministry of Health and Sanitation, Freetown, Sierra Leone.
Kargbo O; National Safe Blood Service, Ministry of Health and Sanitation, Freetown, Sierra Leone.
Doughty HA; National Health Service Blood and Transplant, Birmingham, UK.; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
van Griensven J; Institute of Tropical Medicine, Antwerp, Belgium.
Horby PW; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
Gevao SM; National Safe Blood Service, Ministry of Health and Sanitation, Freetown, Sierra Leone.; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Sahr F; College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.; 34 Military Hospital, Republic of Sierra Leone Armed Forces, Freetown, Sierra Leone.
Dimelow RJ; GlaxoSmithKline, Stevenage, UK.
Tedder RS; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), University of Liverpool, Liverpool, UK.; Blood Borne Virus Unit, National Infection Service, Public Health England, London, UK.; Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.; Division of Infectious Diseases, Imperial College London, London, UK.
Semple MG; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), University of Liverpool, Liverpool, UK.; Faculty of Health and Life Science, University of Liverpool, Liverpool, UK.
Paxton WA; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK.; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), University of Liverpool, Liverpool, UK.
Pollakis G; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool, UK. .; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), University of Liverpool, Liverpool, UK. .
Pokaż więcej
Corporate Authors :
Ebola-CP Consortium
Źródło :
Nature [Nature] 2021 Feb; Vol. 590 (7846), pp. 468-472. Date of Electronic Publication: 2021 Jan 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Convalescence*
Survivors*
Antibodies, Viral/*blood
Antibodies, Viral/*immunology
Ebolavirus/*immunology
Hemorrhagic Fever, Ebola/*immunology
Adolescent ; Adult ; Africa, Western/epidemiology ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Cohort Studies ; Female ; Half-Life ; Hemorrhagic Fever, Ebola/blood ; Hemorrhagic Fever, Ebola/epidemiology ; Hemorrhagic Fever, Ebola/prevention & control ; Humans ; Male ; Middle Aged ; Neutralization Tests ; Time Factors ; Viremia/blood ; Viremia/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
Development of a large spontaneous pneumothorax after recovery from mild COVID-19 infection.
Autorzy :
Nunna K; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Braun AB; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA .
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Jan 18; Vol. 14 (1). Date of Electronic Publication: 2021 Jan 18.
Typ publikacji :
Case Reports; Journal Article; Video-Audio Media
MeSH Terms :
Convalescence*
COVID-19/*complications
Pneumothorax/*etiology
Adult ; COVID-19/physiopathology ; COVID-19 Serological Testing ; Chest Pain/physiopathology ; Chest Tubes ; Cough/physiopathology ; Dyspnea/physiopathology ; Fever/physiopathology ; Humans ; Male ; Myalgia/physiopathology ; Pneumothorax/diagnostic imaging ; Pneumothorax/physiopathology ; Pneumothorax/therapy ; Radiography, Thoracic ; SARS-CoV-2 ; Severity of Illness Index ; Thoracostomy ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Interfacility Neonatal Transport for Convalescent Care: Improving Regionalized Care.
Autorzy :
Shima Y; Department of Neonatal Medicine, Nippon Medical School Musashi Kosugi Hospital.
Matsukawa S; Department of Neonatal Medicine, Nippon Medical School Musashi Kosugi Hospital.
Yashiro K; Department of Neonatal Medicine, Nippon Medical School Musashi Kosugi Hospital.
Migita M; Department of Neonatal Medicine, Nippon Medical School Musashi Kosugi Hospital.
Pokaż więcej
Źródło :
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2021 Jan 08; Vol. 87 (6), pp. 334-338. Date of Electronic Publication: 2020 Mar 31.
Typ publikacji :
Journal Article
MeSH Terms :
Convalescence*
Hospitals, Community*/statistics & numerical data
Intensive Care Units, Neonatal*/statistics & numerical data
Patient Care*
Patient Transfer*/standards
Patient Transfer*/statistics & numerical data
Tertiary Care Centers*/statistics & numerical data
Health Resources/*supply & distribution
Female ; Humans ; Infant, Newborn ; Japan ; Length of Stay ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19.
Autorzy :
An YW; Central laboratory, Shenzhen Samii Medical Center, Shenzhen, Guangdong Province, 518118, China.
Yuan B; Department of neurology, Shenzhen Samii Medical Center, Shenzhen, Guangdong Province, 518118, China.
Wang JC; Central laboratory, Shenzhen Samii Medical Center, Shenzhen, Guangdong Province, 518118, China.
Wang C; Department of neurology, Shenzhen Samii Medical Center, Shenzhen, Guangdong Province, 518118, China.
Liu TT; Department of Traditional Chinese Medicine, Shenzhen Samii Medical Center, Shenzhen, Guangdong Province, 518118, China.
Song S; Central laboratory, Shenzhen Samii Medical Center, Shenzhen, Guangdong Province, 518118, China.
Liu HQ; Central laboratory, Shenzhen Samii Medical Center, Shenzhen, Guangdong Province, 518118, China.
Pokaż więcej
Źródło :
International journal of medical sciences [Int J Med Sci] 2021 Jan 01; Vol. 18 (3), pp. 646-651. Date of Electronic Publication: 2021 Jan 01 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Convalescence*
COVID-19/*rehabilitation
Drugs, Chinese Herbal/*administration & dosage
COVID-19/blood ; COVID-19/diagnosis ; Hospitals, Isolation/statistics & numerical data ; Humans ; Retrospective Studies ; SARS-CoV-2/isolation & purification ; Treatment Outcome
Czasopismo naukowe
Tytuł :
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
Autorzy :
Hansen CB; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Jarlhelt I; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Pérez-Alós L; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Hummelshøj Landsy L; Department of Non-Clinical and Clinical Assay Sciences, Global Discovery and Development Sciences, Novo Nordisk A/S, 2760 Måløv, Denmark.
Loftager M; Department of Non-Clinical and Clinical Assay Sciences, Global Discovery and Development Sciences, Novo Nordisk A/S, 2760 Måløv, Denmark.
Rosbjerg A; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Helgstrand C; Recombinant Technologies, Novo Nordisk A/S, 2760 Måløv, Denmark.
Bjelke JR; Recombinant Technologies, Novo Nordisk A/S, 2760 Måløv, Denmark.
Egebjerg T; Recombinant Technologies, Novo Nordisk A/S, 2760 Måløv, Denmark.
Jardine JG; IAVI Neutralizing Antibody Center, Scripps Research, La Jolla, CA 92037.
Sværke Jørgensen C; Department of Microbiological Diagnostics and Virology, Statens Serum Institut, 2300 Copenhagen, Denmark.
Iversen K; Department of Cardiology, Herlev University Hospital, 2730 Herlev, Denmark; and.
Bayarri-Olmos R; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Garred P; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Skjoedt MO; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; .; Institute of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
Pokaż więcej
Źródło :
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 Jan 01; Vol. 206 (1), pp. 109-117. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Convalescence*
Antibodies, Viral/*immunology
COVID-19/*diagnosis
COVID-19/*immunology
SARS-CoV-2/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Neutralizing/immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunoglobulin A/immunology ; Immunoglobulin G/immunology ; Immunoglobulin M/immunology ; Male ; Middle Aged ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2/genetics ; Severity of Illness Index ; Young Adult
Czasopismo naukowe
Tytuł :
Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.
Autorzy :
Wendel S; Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil.
Kutner JM; Hospital Israelita Albert Einstein Blood Bank, São Paulo, Brazil.
Machado R; Department of Microbiology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.
Fontão-Wendel R; Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil.
Bub C; Hospital Israelita Albert Einstein Blood Bank, São Paulo, Brazil.
Fachini R; Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil.
Yokoyama A; Hospital Israelita Albert Einstein Blood Bank, São Paulo, Brazil.
Candelaria G; Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil.
Sakashita A; Hospital Israelita Albert Einstein Blood Bank, São Paulo, Brazil.
Achkar R; Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil.
Hamerschlak N; Hospital Israelita Albert Einstein Blood Bank, São Paulo, Brazil.
Scuracchio P; Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil.
Amaral M; Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil.
Dal Ben M; Hospital Sírio-Libanês, São Paulo, Brazil.
Araujo D; Department of Microbiology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.
Soares C; Department of Microbiology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.
Camargo A; Hospital Sírio-Libanês, São Paulo, Brazil.
Kallás E; Infectious Disease Department, University of São Paulo Medical School, São Paulo, Brazil.
Durigon E; Department of Microbiology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.
Reis LF; Hospital Sírio-Libanês, São Paulo, Brazil.
Rizzo LV; Albert Einstein Jewish Institute for Education and Research, São Paulo, Brazil.
Pokaż więcej
Źródło :
Transfusion [Transfusion] 2020 Dec; Vol. 60 (12), pp. 2938-2951. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Convalescence*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19/*blood
COVID-19/*therapy
Donor Selection/*statistics & numerical data
SARS-CoV-2/*immunology
Adult ; Blood Donors ; Brazil/epidemiology ; COVID-19/immunology ; COVID-19 Nucleic Acid Testing ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunization, Passive ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Middle Aged ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2/isolation & purification ; Time Factors ; Young Adult
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery.
Autorzy :
Liu A; Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Wang W; Health Management Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Zhao X; Health Management Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Zhou X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Yang D; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Lu M; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, 45147, Germany.
Lv Y; Health Management Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: .
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2020 Dec; Vol. 26 (12), pp. 1703-1705. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
COVID-19 Serological Testing*
Convalescence*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19/*immunology
Adult ; B-Lymphocytes/immunology ; COVID-19/diagnosis ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/immunology
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies